(19)
(11)
EP 1 007 048 A1
(12)
(43)
Date of publication:
14.06.2000
Bulletin 2000/24
(21)
Application number:
98911551.4
(22)
Date of filing:
11.03.1998
(51)
International Patent Classification (IPC)
7
:
A61K
31/54
,
A61K
38/17
,
A61K
49/00
,
A01N
37/12
,
A01N
37/18
,
A01N
43/00
,
A01N
43/32
,
A01N
43/38
,
A01N
43/40
,
A01N
43/60
,
A01N
59/08
,
A01N
59/26
,
C12Q
1/00
,
G01N
33/00
,
G01N
33/20
,
G01N
33/48
,
C07D
209/26
,
C07K
14/47
(86)
International application number:
PCT/US9804/683
(87)
International publication number:
WO 9840/071
(
17.09.1998
Gazette 1998/37)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
11.03.1997
US 816122
(71)
Applicant:
THE GENERAL HOSPITAL CORPORATION
Boston, MA 02110 (US)
(72)
Inventors:
BUSH, Ashley, I.
Somerville, MA 02143 (US)
HUANG, Xudong
Cambridge, MA 02140 (US)
ATWOOD, Craig, S.
Somerville, MA 02143 (US)
TANZI, Rudolph, E.
Hull, MA 02045 (US)
(74)
Representative:
Lee, Nicholas John et al
Kilburn & Strode,20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)
(54)
IDENTIFICATION OF AGENTS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE